196 related articles for article (PubMed ID: 28533673)
21. Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography.
Tapper EB; Sengupta N; Hunink MG; Afdhal NH; Lai M
Am J Gastroenterol; 2015 Sep; 110(9):1298-304. PubMed ID: 26303130
[TBL] [Abstract][Full Text] [Related]
22. Cost-utility analysis of nonalcoholic steatohepatitis screening.
Zhang E; Wartelle-Bladou C; Lepanto L; Lachaine J; Cloutier G; Tang A
Eur Radiol; 2015 Nov; 25(11):3282-94. PubMed ID: 25994191
[TBL] [Abstract][Full Text] [Related]
23. Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard.
Poynard T; de Ledinghen V; Zarski JP; Stanciu C; Munteanu M; Vergniol J; France J; Trifan A; Le Naour G; Vaillant JC; Ratziu V; Charlotte F;
J Hepatol; 2012 Mar; 56(3):541-8. PubMed ID: 21889468
[TBL] [Abstract][Full Text] [Related]
24. Assessment of liver stiffness in patients after living donor liver transplantation by transient elastography.
Masuzaki R; Yamashiki N; Sugawara Y; Yoshida H; Tateishi R; Tamura S; Kaneko J; Hasegawa K; Kokudo N; Makuuchi M; Omata M
Scand J Gastroenterol; 2009; 44(9):1115-20. PubMed ID: 19562623
[TBL] [Abstract][Full Text] [Related]
25. Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis C.
Cobbold JF; Crossey MM; Colman P; Goldin RD; Murphy PS; Patel N; Fitzpatrick J; Vennart W; Thomas HC; Cox IJ; Taylor-Robinson SD
J Viral Hepat; 2010 Aug; 17(8):537-45. PubMed ID: 19804501
[TBL] [Abstract][Full Text] [Related]
26. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
27. Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness.
Stasi C; Milani S
World J Gastroenterol; 2016 Jan; 22(4):1711-20. PubMed ID: 26819535
[TBL] [Abstract][Full Text] [Related]
28. Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease.
Srivastava A; Jong S; Gola A; Gailer R; Morgan S; Sennett K; Tanwar S; Pizzo E; O'Beirne J; Tsochatzis E; Parkes J; Rosenberg W
BMC Gastroenterol; 2019 Jul; 19(1):122. PubMed ID: 31296161
[TBL] [Abstract][Full Text] [Related]
29. Real-time tissue elastography: non-invasive evaluation of liver fibrosis in chronic liver disease due to HCV.
Shiraishi A; Hiraoka A; Aibiki T; Okudaira T; Kawamura T; Imai Y; Tatsukawa H; Yamago H; Nakahara H; Shimizu Y; Suga Y; Azemoto N; Tanihira T; Miyata H; Miyamoto Y; Ninomiya T; Hirooka M; Abe M; Hiasa Y; Matsuura B; Kawasaki H; Furuya K; Michitaka K
Hepatogastroenterology; 2014 Oct; 61(135):2084-90. PubMed ID: 25713914
[TBL] [Abstract][Full Text] [Related]
30. A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies.
Forlano R; Stanic T; Jayawardana S; Mullish BH; Yee M; Mossialos E; Goldin R; Petta S; Tsochatzis E; Thursz M; Manousou P
Liver Int; 2024 Jan; 44(1):61-71. PubMed ID: 37718933
[TBL] [Abstract][Full Text] [Related]
31. Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C.
Guéchot J; Trocmé C; Renversez JC; Sturm N; Zarski JP;
Clin Chem Lab Med; 2012 Jan; 50(4):693-9. PubMed ID: 22505560
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive assessment of liver fibrosis with acoustic radiation force impulse imaging: increased liver and splenic stiffness in patients with liver fibrosis and cirrhosis.
Grgurevic I; Cikara I; Horvat J; Lukic IK; Heinzl R; Banic M; Kujundzic M; Brkljacic B
Ultraschall Med; 2011 Apr; 32(2):160-6. PubMed ID: 21104600
[TBL] [Abstract][Full Text] [Related]
33. Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar-associated protein 4.
Madsen BS; Thiele M; Detlefsen S; Sørensen MD; Kjaergaard M; Møller LS; Rasmussen DN; Schlosser A; Holmskov U; Trebicka J; Sorensen GL; Krag A;
Liver Int; 2020 Jul; 40(7):1701-1712. PubMed ID: 32339377
[TBL] [Abstract][Full Text] [Related]
34. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness analysis of boceprevir for the treatment of chronic hepatitis C virus genotype 1 infection in Portugal.
Elbasha EH; Chhatwal J; Ferrante SA; El Khoury AC; Laires PA
Appl Health Econ Health Policy; 2013 Feb; 11(1):65-78. PubMed ID: 23355388
[TBL] [Abstract][Full Text] [Related]
36. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
[TBL] [Abstract][Full Text] [Related]
37. Liver fibrosis in patients with chronic hepatitis C: noninvasive diagnosis by means of real-time tissue elastography--establishment of the method for measurement.
Koizumi Y; Hirooka M; Kisaka Y; Konishi I; Abe M; Murakami H; Matsuura B; Hiasa Y; Onji M
Radiology; 2011 Feb; 258(2):610-7. PubMed ID: 21273523
[TBL] [Abstract][Full Text] [Related]
38. A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis.
Chan WK; Nik Mustapha NR; Mahadeva S
Hepatol Int; 2015 Oct; 9(4):594-602. PubMed ID: 25788185
[TBL] [Abstract][Full Text] [Related]
39. Liver stiffness measurements to assess progression of fibrosis in HCV-infected patients with inherited bleeding disorders.
Fransen van de Putte DE; Fischer K; de Knegt RJ; Posthouwer D; van Erpecum KJ; Mauser-Bunschoten EP
Haemophilia; 2011 Sep; 17(5):e975-80. PubMed ID: 21535322
[TBL] [Abstract][Full Text] [Related]
40. Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.
Schmid P; Bregenzer A; Huber M; Rauch A; Jochum W; Müllhaupt B; Vernazza P; Opravil M; Weber R;
PLoS One; 2015; 10(9):e0138838. PubMed ID: 26418061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
